Publications
Export 109 results:
Filters: Author is M-A Roy [Clear All Filters]
“Associations between theory of mind and clinical symptoms in recent onset schizophrenia spectrum disorders.”, Front Psychiatry, vol. 14, p. 1044682, 2023.
“Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis.”, Eur Arch Psychiatry Clin Neurosci, vol. 273, no. 7, pp. 1567-1578, 2023.
“Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.”, J Psychopharmacol, vol. 37, no. 4, pp. 370-377, 2023.
“Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study.”, Psychiatry Res, vol. 326, p. 115276, 2023.
“Evaluating romantic and sexual functioning among persons with psychosis: Reliability and validity of two measures.”, Psychiatr Rehabil J, vol. 46, no. 3, pp. 265-271, 2023.
“Gaming Disorder and Psychotic Disorders: A Scoping Review.”, Psychopathology, vol. 56, no. 4, pp. 315-323, 2023.
“Housing trajectories and the risk of homelessness among new mental health service users: Protocol for the AMONT study.”, Early Interv Psychiatry, vol. 17, no. 5, pp. 495-501, 2023.
“Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study).”, BMC Psychiatry, vol. 23, no. 1, p. 383, 2023.
“The other side of the social interaction: Theory of mind impairments in people with schizophrenia are linked to other people's difficulties in understanding them.”, Schizophr Res, vol. 259, pp. 150-157, 2023.
“Problem gambling among people with first-episode psychosis: protocol for a prospective multicenter cohort study.”, BMC Psychiatry, vol. 23, no. 1, p. 287, 2023.
“Sex-specific immune mechanisms in PTSD symptomatology and risk: A translational overview and perspectives.”, Brain Res Bull, vol. 195, pp. 120-129, 2023.
“Short communication: Prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis.”, J Psychiatr Res, vol. 165, pp. 77-82, 2023.
“What areas of everyday functioning are affected by theory of mind deficits in recent-onset schizophrenia spectrum disorders?”, Early Interv Psychiatry, vol. 17, no. 1, pp. 57-64, 2023.
“Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach.”, Acta Psychiatr Scand, vol. 145, no. 5, pp. 469-480, 2022.
“Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study.”, Br J Psychiatry, pp. 1-8, 2022.
“Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study.”, Acta Psychiatr Scand, vol. 145, no. 5, pp. 456-468, 2022.
“For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol.”, BMJ Open, vol. 12, no. 4, p. e048749, 2022.
“Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations.”, Clin Psychopharmacol Neurosci, vol. 20, no. 1, pp. 194-198, 2022.
“Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia.”, Schizophrenia (Heidelb), vol. 8, no. 1, p. 52, 2022.
“A Rapid-Learning Health System to Support Implementation of Early Intervention Services for Psychosis in Quebec, Canada: Protocol.”, JMIR Res Protoc, vol. 11, no. 7, p. e37346, 2022.
“Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation.”, Ther Adv Psychopharmacol, vol. 12, p. 20451253221136021, 2022.
“Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies.”, Eur Psychiatry, vol. 65, no. 1, p. e42, 2022.
“Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC).”, JMIR Res Protoc, vol. 11, no. 11, p. e40817, 2022.
, “A Chart Audit Study of Clozapine Utilization in Early Psychosis.”, J Clin Psychopharmacol, vol. 41, no. 3, pp. 275-280, 2021.
, “Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.”, J Psychopharmacol, vol. 35, no. 9, pp. 1152-1157, 2021.
